Cite
Reduced intensity thiotepa–cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of age.
MLA
Raiola, A. M., et al. “Reduced Intensity Thiotepa–cyclophosphamide Conditioning for Allogeneic Haemopoietic Stem Cell Transplants (HSCT) in Patients up to 60 Years of Age.” British Journal of Haematology, vol. 109, no. 4, June 2000, pp. 716–21. EBSCOhost, https://doi.org/10.1046/j.1365-2141.2000.02123.x.
APA
Raiola, A. M., Van Lint, M. T., Lamparelli, T., Gualandi, F., Mordini, N., Berisso, G., Bregante, S., Frassoni, F., Sessarego, M., Fugazza, G., Di Stefano, F., Pitto, A., & Bacigalupo, A. (2000). Reduced intensity thiotepa–cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of age. British Journal of Haematology, 109(4), 716–721. https://doi.org/10.1046/j.1365-2141.2000.02123.x
Chicago
Raiola, A. M., M. T. Van Lint, T. Lamparelli, F. Gualandi, N. Mordini, G. Berisso, S. Bregante, et al. 2000. “Reduced Intensity Thiotepa–cyclophosphamide Conditioning for Allogeneic Haemopoietic Stem Cell Transplants (HSCT) in Patients up to 60 Years of Age.” British Journal of Haematology 109 (4): 716–21. doi:10.1046/j.1365-2141.2000.02123.x.